Autolus Therapeutics plc
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a AUTL research report →
About the company
Autolus Therapeutics plc is a clinical-stage biopharmaceutical entity primarily focused on pioneering T-cell-based immunotherapies for various oncological conditions. The company's pipeline includes several investigational programs: obecabtagene autoleucel (AUTO1), a CD19-targeting programmed T cell therapy, is currently undergoing Phase 1b/2 trials for adult acute lymphoblastic leukemia (ALL). Additionally, AUTO1/22 is in a Phase 1 study for pediatric patients experiencing relapsed or refractory ALL.
- CEO
- Christian Martin Itin
- IPO
- 2018
- Employees
- 647
- HQ
- London, GB
Price Chart
- Market Cap
- $420.51M
- P/E
- -1.46
- P/S
- 4.54
- P/B
- 3.86
- EV/EBITDA
- -1.60
- Div Yield
- 0.00%
- Gross Margin
- -11.19%
- Op Margin
- -285.90%
- Net Margin
- -311.95%
- ROE
- -128.53%
- ROIC
- -56.74%
- Revenue
- $75.56M · 646.68%
- Net Income
- $-288,199,915 · -30.61%
- EPS
- $-1.08 · -24.14%
- Op Income
- $-281,437,148
- FCF YoY
- -28.87%
- 52W High
- $2.70
- 52W Low
- $1.18
- 50D MA
- $1.59
- 200D MA
- $1.54
- Beta
- 2.03
- Avg Volume
- 1.39M
Get TickerSpark's AI analysis on AUTL
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Jun 29, 26 | YOUNG WILLIAM D | other | 47,500 |
| Jun 29, 26 | YOUNG WILLIAM D | other | 31,667 |
| Jun 29, 26 | Rao Madduri Ravin | other | 47,500 |
| Jun 29, 26 | Rao Madduri Ravin | other | 31,667 |
| Jun 29, 26 | Richardson Ryan | other | 47,500 |
| Jun 29, 26 | Richardson Ryan | other | 31,667 |
| Jun 29, 26 | Leiderman Elisabeth | other | 47,500 |
| Jun 29, 26 | Leiderman Elisabeth | other | 31,667 |
| Jun 29, 26 | Iannone Robert | other | 47,500 |
| Jun 29, 26 | Iannone Robert | other | 31,667 |
Our AUTL coverage
Recent articles, reports, and earnings notes.
Want a deeper read on AUTL?
Generate a full analyst-grade report — bull/bear case, price targets, valuation depth, and a complete financial breakdown.
Similar companies
Peers in the same neighborhood.